Early amiodarone for shockable cardiac arrest
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests whether giving the heart rhythm medicine amiodarone early after a shockable cardiac arrest improves survival. If you had a cardiac arrest due to a heart rhythm problem that didn't stop after the first shock, this study may be for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a cardiac arrest that was not caused by an injury
- The first heart rhythm emergency workers saw was ventricular fibrillation or ventricular tachycardia
- The abnormal rhythm came back or didn't stop after the first defibrillator shock
- You are not allergic to the study drug amiodarone
- You do not have a 'do not resuscitate' order
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using a machine to pump blood and oxygen (ECPR) right after a witnessed cardiac arrest with a shockable rhythm can improve survival. You might be eligible if you had a witnessed arrest, got bystander CPR, and your first rhythm was shockable, as long as the emergency team can reach the hospital in 30 minutes.
This trial tests a new way of giving two quick shocks to restart the heart in people who have a cardiac arrest outside the hospital. If you had a shockable heart rhythm, this approach might help improve your chances of survival.
This trial tests whether a combination of three medications (epinephrine, vasopressin, and a steroid) given by paramedics before arriving at the hospital can improve survival for adults who have a cardiac arrest outside of a hospital. It is only for patients who are treated by specially trained paramedics and meet specific medical criteria.
This trial tests whether giving the drug amiodarone early can prevent dangerous heart rhythm problems in patients who survived a cardiac arrest with a shockable rhythm. If it works, it could help more people recover.
This trial tests two different ways of taking amiodarone (a heart rhythm medicine) to keep your heart in a normal rhythm after a procedure called electrical cardioversion. It's designed for people with persistent atrial fibrillation (a fast, irregular heartbeat lasting at least 7 days).
This trial is testing whether giving amiodarone (a heart-rhythm medicine) before an electrical cardioversion can help restore normal heart rhythm better in people with persistent atrial fibrillation. The goal is to see if the medicine makes the procedure more likely to succeed and reduces the chance of the irregular rhythm returning.
Hear when a new Cardiac Arrest trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.